ENO2 and prostate cancer: Besides, Kaplan-Meier analysis also showed that patients with a higher grade of PSCA and NSE expressions had significantly poorer survival than those with lower expressions of these markers in prostate cancer patients (P = 0.005 and P = 0.001, respectively; Figure 4).